Technical Data Sheet
CJC-1295 Without DAC
Also Known As: CJC-1295 no DAC, Mod GRF 1-29, Modified GRF 1-29, Modified GRF, ModGRF, CJC1295 without DAC, Sermorelin analog, GHRH 1-29 analog, Growth hormone releasing hormone 1-29, CJC 1295 no-DAC, Short-acting GHRH analog, Modified growth releasing factor, GRF 1-29 tetrasubstituted, MOD GRF 1-29, GHRH, growth hormone releasing hormone, CJC 1295, CJC no DAC
Scan To View Profile
| Evidence Tier | Research Compound |
|---|---|
| Category | Muscle Growth & Performance |
| Class | Short-acting synthetic GHRH analog (Mod GRF 1-29); no albumin-binding DAC moiety |
| Molecular Target | GHRH receptor (GHRHR) on anterior pituitary somatotrophs; augments natural pulsatile GH release |
| Sequence | tetrasubstituted GRF(1-29) amide |
| Molecular Weight | ~3368 Da |
| CAS | 863288-34-0 |
| Parent | Growth hormone releasing factor |
| Mechanism | It perfectly mimics your natural growth hormone-releasing hormone. It connects to the pituitary gland to trigger a fast, natural spike in growth hormone, then breaks down completely within about 30 minutes. |
| Studied For | Pulsatile GH simulation, GH secretagogue research, Sleep quality improvement, Stacked with ipamorelin for synergistic GH release, Anti-aging via GH axis, Body composition / lean mass, GH deficiency models, Fat loss via GH axis, Recovery and tissue repair via GH, Bone density support, IGF-1 elevation, Collagen synthesis promotion, Skin quality research, Athletic performance research, GH pulse amplitude enhancement, muscle growth, fat loss, deep sleep, anti-aging, vitality, collagen production, recovery |
| Administration Route | Injection Only |
| Form | lyophilized |
| Diluent | bacteriostatic or sterile water |
| Storage Temperature | cold, dark |
| Light Sensitive | Yes |
| Freeze / Thaw | avoid |
| Reconstituted Shelf Life | 28 Days |
| Handling Notes | Short half-life; often co-administered with a GHRP. |
| Regulatory | Not FDA-approved; research chemical; WADA S2. |
| Sources |